Announcement — 2026.03.03
Emeraid, Inc. (Headquarters: Bunkyo-ku, Tokyo; CEO: Rikuto Shima) has fully renewed its corporate website on March 3, 2026.
For any inquiries, please feel free to contact us.
As we mark our second anniversary since founding, we have redesigned our corporate website to more accurately communicate our philosophy, business operations, and technology in line with the expansion of our business domains and the growth of our team.
Emeraid is a University of Tokyo venture company that upholds the philosophy of "A society where everyone can face 'living' head-on," aiming to optimize and sustain healthcare — the very infrastructure of life — through AI-DX. Leveraging domain knowledge and problem understanding specialized in the healthcare industry, combined with cutting-edge technology centered on AI, Emeraid creates future-oriented solutions for the complex challenges faced by medical institutions and companies.
Built on its proprietary Healthcare AI Platform "SUI" — a technology foundation developed through in-house R&D and medical research — the company provides a Solutions Business offering end-to-end support spanning AI, software, and hardware, from issue analysis to system development and operational improvement, as well as Medical Data Analytics grounded in bioinformatics and chemoinformatics for clinical research and trials.